-
1
-
-
0033040354
-
Treatment of colorectal liver metastases
-
PID: 10100781, COI: 1:STN:280:DyaK1M7pvVyrsg%3D%3D
-
Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg. 1999;86:158–69.
-
(1999)
Br J Surg
, vol.86
, pp. 158-169
-
-
Geoghegan, J.G.1
Scheele, J.2
-
2
-
-
35648981122
-
Actual 10- year survival after resection of colorectal liver metastases defines cure
-
Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, Kemeny N, Brennan MF, Blumgart LH, D’Angelica M. Actual 10- year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;10(25):4575–80.
-
(2007)
J Clin Oncol
, vol.10
, Issue.25
, pp. 4575-4580
-
-
Tomlinson, J.S.1
Jarnagin, W.R.2
DeMatteo, R.P.3
Fong, Y.4
Kornprat, P.5
Gonen, M.6
Kemeny, N.7
Brennan, M.F.8
Blumgart, L.H.9
D’Angelica, M.10
-
3
-
-
33746658649
-
Molecular prognostic markers in resectable colorectal liver metastases: a systematic review
-
PID: 16815701, COI: 1:CAS:528:DC%2BD28XotFyltL0%3D
-
Neal CP, Garcea G, Doucas H, Manson MM, Sutton CD, Dennison AR, Berry DP. Molecular prognostic markers in resectable colorectal liver metastases: a systematic review. Eur J Cancer. 2006;42:1728–43.
-
(2006)
Eur J Cancer
, vol.42
, pp. 1728-1743
-
-
Neal, C.P.1
Garcea, G.2
Doucas, H.3
Manson, M.M.4
Sutton, C.D.5
Dennison, A.R.6
Berry, D.P.7
-
4
-
-
8744279986
-
Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver
-
Tanaka K, Shimada H, Fujii Y, Endo I, Sekido H, Togo S, Ike H. Pre-hepatectomy prognostic staging to determine treatment strategy for colorectal cancer metastases to the liver. Arch Surg. 2004;389:371–9.
-
(2004)
Arch Surg
, vol.389
, pp. 371-379
-
-
Tanaka, K.1
Shimada, H.2
Fujii, Y.3
Endo, I.4
Sekido, H.5
Togo, S.6
Ike, H.7
-
5
-
-
0033504042
-
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of, 1001 consecutive cases
-
PID: 10493478, COI: 1:STN:280:DyaK1MvitFahsw%3D%3D
-
Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of, 1001 consecutive cases. Ann Surg. 1999;230:309–21.
-
(1999)
Ann Surg
, vol.230
, pp. 309-321
-
-
Fong, Y.1
Fortner, J.2
Sun, R.L.3
Brennan, M.F.4
Blumgart, L.H.5
-
6
-
-
0035901090
-
Inflammation and cancer: back to Virchow?
-
PID: 11229684, COI: 1:CAS:528:DC%2BD3MXhsVKltb0%3D
-
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–45.
-
(2001)
Lancet
, vol.357
, pp. 539-545
-
-
Balkwill, F.1
Mantovani, A.2
-
7
-
-
0037180757
-
Inflammation and cancer
-
PID: 12490959, COI: 1:CAS:528:DC%2BD38XpsFygtb4%3D
-
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.
-
(2002)
Nature
, vol.420
, pp. 860-867
-
-
Coussens, L.M.1
Werb, Z.2
-
8
-
-
0023778137
-
Meyer zum Buschenfelde KH. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha
-
Ramadori G, Van Damme J, Rieder H. Meyer zum Buschenfelde KH. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur J Immunol. 1998;18:1259–64.
-
(1998)
Eur J Immunol
, vol.18
, pp. 1259-1264
-
-
Ramadori, G.1
Van Damme, J.2
Rieder, H.3
-
9
-
-
36048991069
-
Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases
-
PID: 17978466, COI: 1:CAS:528:DC%2BD1cXisVCntQ%3D%3D
-
Ohsugi Y. Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases. Biol Pharm Bull. 2007;30:2001–6.
-
(2007)
Biol Pharm Bull
, vol.30
, pp. 2001-2006
-
-
Ohsugi, Y.1
-
10
-
-
84868384472
-
Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer
-
PID: 22623286
-
Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K. Preoperative thrombocytosis is associated with survival after surgery for colorectal cancer. J Surg Oncol. 2012;106:887–91.
-
(2012)
J Surg Oncol
, vol.106
, pp. 887-891
-
-
Ishizuka, M.1
Nagata, H.2
Takagi, K.3
Iwasaki, Y.4
Kubota, K.5
-
11
-
-
77955894120
-
Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio
-
PID: 20122680
-
Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg. 2010;200:197–203.
-
(2010)
Am J Surg
, vol.200
, pp. 197-203
-
-
Bhatti, I.1
Peacock, O.2
Lloyd, G.3
Larvin, M.4
Hall, R.I.5
-
12
-
-
79954430604
-
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer
-
PID: 21448173, COI: 1:CAS:528:DC%2BC3MXks1ajur8%3D
-
Chua W, Charles KA, Baracos VE, Clarke SJ. Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer. 2011;104:1288–95.
-
(2011)
Br J Cancer
, vol.104
, pp. 1288-1295
-
-
Chua, W.1
Charles, K.A.2
Baracos, V.E.3
Clarke, S.J.4
-
13
-
-
0014951275
-
Thrombocytosis in patients with lung cancer
-
PID: 5467116, COI: 1:STN:280:DyaE3c7htl2nuw%3D%3D
-
Silvis SE, Turkbas N, Doscherholmen A. Thrombocytosis in patients with lung cancer. JAMA. 1970;211:1852–3.
-
(1970)
JAMA
, vol.211
, pp. 1852-1853
-
-
Silvis, S.E.1
Turkbas, N.2
Doscherholmen, A.3
-
14
-
-
0031976339
-
Platelet count and survival in patients with colorectal cancer: a preliminary study
-
PID: 9609220, COI: 1:CAS:528:DyaK1cXivFyksr8%3D
-
Monreal M, Fernandez-Llamazares J, Pinol M, Julian JF, Broggi M, Escola D, Abad A. Platelet count and survival in patients with colorectal cancer: a preliminary study. Thromb Haemost. 1998;79:916–8.
-
(1998)
Thromb Haemost
, vol.79
, pp. 916-918
-
-
Monreal, M.1
Fernandez-Llamazares, J.2
Pinol, M.3
Julian, J.F.4
Broggi, M.5
Escola, D.6
Abad, A.7
-
15
-
-
2142707165
-
Thrombocytosis associated with poor prognosis in patients with oesophageal carcinoma
-
PID: 15110807
-
Shimada H, Oohira G, Okazumi S, Matsubara H, Nabeya Y, Hayashi H, Takeda A, Gunji Y, Ochiai T. Thrombocytosis associated with poor prognosis in patients with oesophageal carcinoma. J Am Coll Surg. 2004;198:737–41.
-
(2004)
J Am Coll Surg
, vol.198
, pp. 737-741
-
-
Shimada, H.1
Oohira, G.2
Okazumi, S.3
Matsubara, H.4
Nabeya, Y.5
Hayashi, H.6
Takeda, A.7
Gunji, Y.8
Ochiai, T.9
-
16
-
-
84905090341
-
The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients
-
PID: 24581872
-
Szkandera J, Pichler M, Absenger G, Stotz M, Arminger F, Weissmueller M, Schaberl-Moser R, Samonigg H, Kornprat P, Stojakovic T, Avian A, Gerger A. The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients. Am J Surg. 2014;208:210–4.
-
(2014)
Am J Surg
, vol.208
, pp. 210-214
-
-
Szkandera, J.1
Pichler, M.2
Absenger, G.3
Stotz, M.4
Arminger, F.5
Weissmueller, M.6
Schaberl-Moser, R.7
Samonigg, H.8
Kornprat, P.9
Stojakovic, T.10
Avian, A.11
Gerger, A.12
-
17
-
-
84892910540
-
The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
-
PID: 24357796, COI: 1:STN:280:DC%2BC2c3nvFaisQ%3D%3D
-
Stotz M, Pichler M, Absenger G, Szkandera J, Arminger F, Schaberl-Moser R, Samonigg H, Stojakovic T, Gerger A. The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer. 2014;110:435–40.
-
(2014)
Br J Cancer
, vol.110
, pp. 435-440
-
-
Stotz, M.1
Pichler, M.2
Absenger, G.3
Szkandera, J.4
Arminger, F.5
Schaberl-Moser, R.6
Samonigg, H.7
Stojakovic, T.8
Gerger, A.9
-
18
-
-
4143141823
-
The immunobiology of cancer immunosurveillance and immunoediting
-
PID: 15308095, COI: 1:CAS:528:DC%2BD2cXnsVKltrY%3D
-
Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21:137–48.
-
(2004)
Immunity
, vol.21
, pp. 137-148
-
-
Dunn, G.P.1
Old, L.J.2
Schreiber, R.D.3
-
19
-
-
0036023415
-
Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance
-
PID: 12171883
-
Hoffmann TK, Dworacki G, Tsukihiro T, Meidenbauer N, Gooding W, Johnson JT, Whiteside TL. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance. Clin Cancer Res. 2002;8:2553–62.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 2553-2562
-
-
Hoffmann, T.K.1
Dworacki, G.2
Tsukihiro, T.3
Meidenbauer, N.4
Gooding, W.5
Johnson, J.T.6
Whiteside, T.L.7
-
20
-
-
84858800620
-
The immune contexture in human tumours: impact on clinical outcome
-
PID: 22419253, COI: 1:CAS:528:DC%2BC38Xjslersb4%3D
-
Fridman WH, Pages F, Sautes-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12:298–306.
-
(2012)
Nat Rev Cancer
, vol.12
, pp. 298-306
-
-
Fridman, W.H.1
Pages, F.2
Sautes-Fridman, C.3
Galon, J.4
-
21
-
-
53149083361
-
Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
-
PID: 18671239, COI: 1:CAS:528:DC%2BD1cXhtFyls7rL
-
Kawai O, Ishii G, Kubota K, Murata Y, Naito Y, Mizuno T, Aokage K, Saijo N, Nishiwaki Y, Gemma A, Kudoh S, Ochiai A. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer. 2008;113:1387–95.
-
(2008)
Cancer
, vol.113
, pp. 1387-1395
-
-
Kawai, O.1
Ishii, G.2
Kubota, K.3
Murata, Y.4
Naito, Y.5
Mizuno, T.6
Aokage, K.7
Saijo, N.8
Nishiwaki, Y.9
Gemma, A.10
Kudoh, S.11
Ochiai, A.12
-
22
-
-
84905500282
-
Does the immune system naturally protect against cancer?
-
PID: 24860567
-
Corthay A. Does the immune system naturally protect against cancer? Front Immunol. 2014;5:197.
-
(2014)
Front Immunol
, vol.5
, pp. 197
-
-
Corthay, A.1
-
23
-
-
84879100801
-
Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors
-
PID: 23592754, COI: 1:CAS:528:DC%2BC3sXpsVensr0%3D
-
Rusakiewicz S, Semeraro M, Sarabi M, Desbois M, Locher C, Mendez R, Vimond N, Concha A, Garrido F, Isambert N, Chaigneau L, Le Brun-Ly V, Dubreuil P, Cremer I, Caignard A, Poirier-Colame V, Chaba K, Flament C, Halama N, Jäger D, Eggermont A, Bonvalot S, Commo F, Terrier P, Opolon P, Emile JF, Coindre JM, Kroemer G, Chaput N, Le Cesne A, Blay JY, Zitvogel L. Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors. Cancer Res. 2013;73:3499–510.
-
(2013)
Cancer Res
, vol.73
, pp. 3499-3510
-
-
Rusakiewicz, S.1
Semeraro, M.2
Sarabi, M.3
Desbois, M.4
Locher, C.5
Mendez, R.6
Vimond, N.7
Concha, A.8
Garrido, F.9
Isambert, N.10
Chaigneau, L.11
Le Brun-Ly, V.12
Dubreuil, P.13
Cremer, I.14
Caignard, A.15
Poirier-Colame, V.16
Chaba, K.17
Flament, C.18
Halama, N.19
Jäger, D.20
Eggermont, A.21
Bonvalot, S.22
Commo, F.23
Terrier, P.24
Opolon, P.25
Emile, J.F.26
Coindre, J.M.27
Kroemer, G.28
Chaput, N.29
Le Cesne, A.30
Blay, J.Y.31
Zitvogel, L.32
more..
-
24
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and treatment Of cancer, National cancer Institute of the United States, National cancer Institute of Canada
-
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and treatment Of cancer, National cancer Institute of the United States, National cancer Institute of Canada. J Natl Cancer Inst. 2000;2(92):205–16.
-
(2000)
J Natl Cancer Inst
, vol.2
, Issue.92
, pp. 205-216
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
Verweij, J.7
Van Glabbeke, M.8
van Oosterom, A.T.9
Christian, M.C.10
Gwyther, S.G.11
-
25
-
-
33846497237
-
C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases
-
PID: 17211465, COI: 1:CAS:528:DC%2BD2sXotFekug%3D%3D
-
Wong VK, Malik HZ, Hamady ZZ, Al-Mukhtar A, Gomez D, Prasad KR, Toogood GJ, Lodge JP. C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer. 2007;96:222–5.
-
(2007)
Br J Cancer
, vol.96
, pp. 222-225
-
-
Wong, V.K.1
Malik, H.Z.2
Hamady, Z.Z.3
Al-Mukhtar, A.4
Gomez, D.5
Prasad, K.R.6
Toogood, G.J.7
Lodge, J.P.8
-
26
-
-
37349054395
-
Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases
-
PID: 17448623, COI: 1:STN:280:DC%2BD2sjlvFKksw%3D%3D
-
Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JP. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol. 2008;34:55–60.
-
(2008)
Eur J Surg Oncol
, vol.34
, pp. 55-60
-
-
Halazun, K.J.1
Aldoori, A.2
Malik, H.Z.3
Al-Mukhtar, A.4
Prasad, K.R.5
Toogood, G.J.6
Lodge, J.P.7
-
27
-
-
84898847636
-
The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases
-
PID: 24452408
-
Nakagawa K, Tanaka K, Nojiri K, Kumamoto T, Takeda K, Ueda M, Endo I. The modified Glasgow prognostic score as a predictor of survival after hepatectomy for colorectal liver metastases. Ann Surg Oncol. 2014;21:1711–8.
-
(2014)
Ann Surg Oncol
, vol.21
, pp. 1711-1718
-
-
Nakagawa, K.1
Tanaka, K.2
Nojiri, K.3
Kumamoto, T.4
Takeda, K.5
Ueda, M.6
Endo, I.7
-
28
-
-
84867172020
-
Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer
-
PID: 23094130
-
Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, Thavaramara T. Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. J Gynecol Oncol. 2012;23:265–73.
-
(2012)
J Gynecol Oncol
, vol.23
, pp. 265-273
-
-
Raungkaewmanee, S.1
Tangjitgamol, S.2
Manusirivithaya, S.3
Srijaipracharoen, S.4
Thavaramara, T.5
-
29
-
-
82255162065
-
Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer
-
PID: 21775277
-
Asher V, Lee J, Innamaa A, Bali A. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol. 2011;13:499–503.
-
(2011)
Clin Transl Oncol
, vol.13
, pp. 499-503
-
-
Asher, V.1
Lee, J.2
Innamaa, A.3
Bali, A.4
-
30
-
-
62649085200
-
Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
-
PID: 18639229
-
Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, Ghaneh P. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197:466–72.
-
(2009)
Am J Surg
, vol.197
, pp. 466-472
-
-
Smith, R.A.1
Bosonnet, L.2
Raraty, M.3
Sutton, R.4
Neoptolemos, J.P.5
Campbell, F.6
Ghaneh, P.7
-
31
-
-
84860358285
-
Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer
-
PID: 22424597, COI: 1:CAS:528:DC%2BC38Xmt1Shsbc%3D
-
Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ, Park KJ, Roh MS, Kim SG, Kim HJ, Lee JH. Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers. 2012;17:216–22.
-
(2012)
Biomarkers
, vol.17
, pp. 216-222
-
-
Kwon, H.C.1
Kim, S.H.2
Oh, S.Y.3
Lee, S.4
Lee, J.H.5
Choi, H.J.6
Park, K.J.7
Roh, M.S.8
Kim, S.G.9
Kim, H.J.10
Lee, J.H.11
-
32
-
-
84891600524
-
Preoperative platelet-lymphocyte ratio is an independent prognostic factor for resectable colorectal cancer
-
PID: 23353160
-
Liu H, DU X, Sun P, Xiao C, Xu Y, Li R. Preoperative platelet-lymphocyte ratio is an independent prognostic factor for resectable colorectal cancer. Nan Fang Yi Ke Da Xue Xue Bao. 2013;33:70–3.
-
(2013)
Nan Fang Yi Ke Da Xue Xue Bao
, vol.33
, pp. 70-73
-
-
Liu, H.1
DU, X.2
Sun, P.3
Xiao, C.4
Xu, Y.5
Li, R.6
-
33
-
-
84880576750
-
Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer
-
PID: 23307251
-
He W, Yin C, Guo G, Jiang C, Wang F, Qiu H, Chen X, Rong R, Zhang B, Xia L. Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol. 2013;30:439.
-
(2013)
Med Oncol
, vol.30
, pp. 439
-
-
He, W.1
Yin, C.2
Guo, G.3
Jiang, C.4
Wang, F.5
Qiu, H.6
Chen, X.7
Rong, R.8
Zhang, B.9
Xia, L.10
-
34
-
-
84876485422
-
Platelets: bridging hemostasis, inflammation, and immunity
-
PID: 23590652, COI: 1:STN:280:DC%2BC3srlvVektg%3D%3D
-
Jenne CN, Urrutia R, Kubes P. Platelets: bridging hemostasis, inflammation, and immunity. Int J Lab Hematol. 2013;35:254–61.
-
(2013)
Int J Lab Hematol
, vol.35
, pp. 254-261
-
-
Jenne, C.N.1
Urrutia, R.2
Kubes, P.3
-
35
-
-
80054005719
-
Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells
-
PID: 22022533, COI: 1:CAS:528:DC%2BC3MXhsVSgsbrE
-
Egan K, Crowley D, Smyth P, O’Toole S, Spillane C, Martin C, Gallagher M, Canney A, Norris L, Conlon N, McEvoy L, Ffrench B, Stordal B, Keegan H, Finn S, McEneaney V, Laios A, Ducrée J, Dunne E, Smith L, Berndt M, Sheils O, Kenny D, O’Leary J. Platelet adhesion and degranulation induce pro-survival and pro-angiogenic signalling in ovarian cancer cells. PLoS One. 2011;6:e26125.
-
(2011)
PLoS One
, vol.6
, pp. e26125
-
-
Egan, K.1
Crowley, D.2
Smyth, P.3
O’Toole, S.4
Spillane, C.5
Martin, C.6
Gallagher, M.7
Canney, A.8
Norris, L.9
Conlon, N.10
McEvoy, L.11
Ffrench, B.12
Stordal, B.13
Keegan, H.14
Finn, S.15
McEneaney, V.16
Laios, A.17
Ducrée, J.18
Dunne, E.19
Smith, L.20
Berndt, M.21
Sheils, O.22
Kenny, D.23
O’Leary, J.24
more..
-
36
-
-
3242763172
-
The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents
-
PID: 15257105, COI: 1:CAS:528:DC%2BD2cXmvF2ks7Y%3D
-
Suzuki K, Aiura K, Ueda M, Kitajima M. The influence of platelets on the promotion of invasion by tumor cells and inhibition by antiplatelet agents. Pancreas. 2004;29:132–40.
-
(2004)
Pancreas
, vol.29
, pp. 132-140
-
-
Suzuki, K.1
Aiura, K.2
Ueda, M.3
Kitajima, M.4
-
37
-
-
84879777241
-
Nivolumab plus ipilimumab in advanced melanoma
-
PID: 23724867, COI: 1:CAS:528:DC%2BC3sXht1ektbrF
-
Wolchok JD, Kluger H, Callahan MK, Postow MA, Rizvi NA, Lesokhin AM, Segal NH, Ariyan CE, Gordon RA, Reed K, Burke MM, Caldwell A, Kronenberg SA, Agunwamba BU, Zhang X, Lowy I, Inzunza HD, Feely W, Horak CE, Hong Q, Korman AJ, Wigginton JM, Gupta A, Sznol M. Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med. 2013;369:122–33.
-
(2013)
N Engl J Med
, vol.369
, pp. 122-133
-
-
Wolchok, J.D.1
Kluger, H.2
Callahan, M.K.3
Postow, M.A.4
Rizvi, N.A.5
Lesokhin, A.M.6
Segal, N.H.7
Ariyan, C.E.8
Gordon, R.A.9
Reed, K.10
Burke, M.M.11
Caldwell, A.12
Kronenberg, S.A.13
Agunwamba, B.U.14
Zhang, X.15
Lowy, I.16
Inzunza, H.D.17
Feely, W.18
Horak, C.E.19
Hong, Q.20
Korman, A.J.21
Wigginton, J.M.22
Gupta, A.23
Sznol, M.24
more..
-
38
-
-
84903381578
-
The therapeutic value of targeting inflammation in gastrointestinal cancers
-
PID: 24881011, COI: 1:CAS:528:DC%2BC2cXosl2hsrY%3D
-
Sun B, Karin M. The therapeutic value of targeting inflammation in gastrointestinal cancers. Trends Pharmacol Sci. 2014;35:349–57.
-
(2014)
Trends Pharmacol Sci
, vol.35
, pp. 349-357
-
-
Sun, B.1
Karin, M.2
-
39
-
-
0037234156
-
The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer
-
PID: 12680220, COI: 1:CAS:528:DC%2BD3sXislaqtrk%3D
-
Yamauchi T, Watanabe M, Hasegawa H, Nishibori H, Ishii Y, Tatematsu H, Yamamoto K, Kubota T, Kitajima M. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer. Anticancer Res. 2003;23:245–9.
-
(2003)
Anticancer Res
, vol.23
, pp. 245-249
-
-
Yamauchi, T.1
Watanabe, M.2
Hasegawa, H.3
Nishibori, H.4
Ishii, Y.5
Tatematsu, H.6
Yamamoto, K.7
Kubota, T.8
Kitajima, M.9
|